NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

臉部注射劑的市場趨勢·市場佔有率·市場規模的預測 (2021-2028年):產品·用途·各地區

Facial Injectable Market Size, Share & Trends Analysis Report By Product (Collagen, Hyaluronic Acid, Botulinum Toxin Type A, Calcium Hydroxylapatite, Polymer Fillers), By Application (Aesthetic, Therapeutic), By Region, & Segment Forecasts, 2021-2028

出版商 Grand View Research, Inc. 商品編碼 1026792
出版日期 內容資訊 英文 172 Pages
商品交期: 2-10個工作天內
價格
臉部注射劑的市場趨勢·市場佔有率·市場規模的預測 (2021-2028年):產品·用途·各地區 Facial Injectable Market Size, Share & Trends Analysis Report By Product (Collagen, Hyaluronic Acid, Botulinum Toxin Type A, Calcium Hydroxylapatite, Polymer Fillers), By Application (Aesthetic, Therapeutic), By Region, & Segment Forecasts, 2021-2028
出版日期: 2021年08月26日內容資訊: 英文 172 Pages
簡介

全球臉部注射劑的市場規模在預測期間內預計將以8.8%的年複合成長率推移,到2028年達到277億美元的規模。

尤其是在新興國家,越來越強調審美,這被認為是推動市場的主要因素之一。微創手術的趨勢也有望推動市場增長。

本報告提供全球臉部注射劑的市場調查,彙整市場定義和概要,市場成長的各種影響因素分析,市場規模的轉變·預測,產品·用途·地區/主要國家等各種區分的明細,競爭環境,市場佔有率,主要企業簡介等資訊。

第1章 調查手法·調查範圍

第2章 摘要整理

第3章 市場可變因素·趨勢·展望

  • 普及·成長預測製圖
  • 市場動態
  • 非侵入性審美治療:市場分析工具

第4章 市場分析·預測:各產品

  • 膠原蛋白
  • A型肉毒桿菌
  • 玻尿酸 (HA)
  • 羥磷石灰鈣 (CaHA)
  • 聚合物填充物

第5章 市場分析·預測:各用途

  • 美容
  • 治療

第6章 市場分析·預測:地區·各主要國家

  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第7章 競爭分析

  • 主要企業·競爭上的分類
  • 業者情勢
  • 主要企業的簡介
    • ALLERGAN
    • Ipsen
    • Merz Pharma
    • Suneva Medical, Inc.
    • Medytox Inc.
    • Sinclair Pharma
    • Bloomage BioTechnology Corporation Limited
    • Anika Therapeutics, Inc.
    • Prollenium Medical Technologies Inc.
    • Galderma S.A
目錄
Product Code: GVR-1-68038-849-7

Facial Injectable Market Growth & Trends:

The global facial injectable market size is expected to reach USD 27.7 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 8.8% from 2021 to 2028. The facial injectable is a substance that is used to reduce wrinkles and restore volume and fullness in the face. It is injected beneath the facial skin surface. Some commonly used facial injectables include hyaluronic acid, botulinum toxin type A, and polymer fillers.

The growing focus on physical appearance, especially in developing countries, is one of the key factors expected to drive the market. In addition, a shift in consumer preference toward minimally invasive procedures is expected to support market growth. According to the American Society of Plastic Surgeons (ASPS), in 2019, botulinum toxin A and soft tissue fillers were among the top 5 minimally invasive procedures carried out in the U.S. Thus, facial injectable holds high growth prospects in the years to come.

The Asia Pacific region is expected to serve as a key revenue-generating center. The region is backed by countries, such as India, where a growing focus on physical appearance is expected to create a lucrative opportunity for the market. Companies such as Allergan are also expanding their presence in the country owing to the rise in the middle-class population, backed by increasing disposable income.

With non-urgent and cosmetic surgeries being put on hold in most of the clinics across the world, surgeons are consulting their patients via telemedicine. Some surgeons are expecting an initial rush once the clinic reopens due to backlog cases, however, in the long run, they predict changes in the near future. There will also be an additional impact on revenue. With deep sanitization and PPEs to be worn for even injectable procedures, small businesses are expected to undergo the overhead expense and a decreased revenue, many could even shut down.

Facial Injectable Market Report Highlights:

  • By product, the botulinum toxin type A segment led the market in 2020 and is projected to dominate throughout the forecast period. It is one of the most popularly used minimally invasive procedures
  • Based on application, the aesthetics segment is projected to be the fastest-growing segment over the forecast period owing to the rise in the use of facial injectables for aesthetic procedures, such as the treatment of wrinkles on the face
  • North America dominated the market in 2020 with a share of over 41.0% owing to the easy availability of the products and the presence of a large number of skilled surgeons

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market segmentation & scope
  • 1.2. Information procurement
    • 1.2.1. Purchased database
    • 1.2.2. GVR's internal database
    • 1.2.3. Secondary sources & third-party perspectives
    • 1.2.4. Primary research
  • 1.3. Information analysis
    • 1.3.1. Data analysis models
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing

Chapter 2. Executive Summary

Chapter 3. Facial Injectable Market Variables, Trends & Scope

  • 3.1. Penetration & Growth Prospect Mapping
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing beauty consciousness among consumers
      • 3.2.1.2. Shift in consumer preference towards minimally invasive procedures
    • 3.2.2. Market Restraint Analysis
  • 3.3. Non-invasive Aesthetic Treatment: Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat from new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political Landscape
      • 3.3.2.2. Social Landscape
      • 3.3.2.3. Technology Landscape
      • 3.3.2.4. Legal Landscape

Chapter 4. Facial Injectable Market: Segment Analysis, By Product, 2016 - 2028 (USD Million, & Number of Procedures)

  • 4.1. Definitions & Scope
  • 4.2. Product market share analysis, 2020 & 2028
  • 4.3. Global Facial Injectable Market, By Product, 2016 - 2028
  • 4.4. Market Size & Forecasts and Trend Analyses, 2016 - 2028 for the following
    • 4.4.1. Collagen
    • 4.4.2. Botulinum Toxin Type A
    • 4.4.3. Hyaluronic Acid (HA)
    • 4.4.4. Calcium Hydroxylapatite (CaHA)
    • 4.4.5. Polymer Fillers

Chapter 5. Facial Injectable Market: Segment Analysis, By Application, 2016 - 2028 (USD Million)

  • 5.1. Definitions & Scope
  • 5.2. Product market share analysis, 2020 & 2028
  • 5.3. Global Facial Injectable Market, By Application, 2016 - 2028
  • 5.4. Market Size & Forecasts and Trend Analyses, 2016 - 2028 for the following
    • 5.4.1. Aesthetic
    • 5.4.2. Therapeutic

Chapter 6. Facial Injectable Market: Regional Market Analysis, By Region, 2016 - 2028 (USD Million)

  • 6.1. Definitions & Scope
  • 6.2. Regional market share analysis, 2020 & 2028
  • 6.3. Regional Market Dashboard
  • 6.4. Market Size, & Forecasts, and Trend Analysis, 2020 to 2028:
  • 6.5. North America
    • 6.5.1. Market estimates and forecast, by country, 2016 - 2028 (USD Million)
    • 6.5.2. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
    • 6.5.3. Market volume and forecast, by product, 2016 - 2028 (Number of procedures)
    • 6.5.4. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
    • 6.5.5. U.S.
      • 6.5.5.1. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
      • 6.5.5.2. Market volume and forecast, by product, 2016 - 2028 (Number of procedures)
      • 6.5.5.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
    • 6.5.6. Canada
      • 6.5.6.1. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
      • 6.5.6.2. Market volume and forecast, by product, 2016 - 2028 (Number of procedures)
      • 6.5.6.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
  • 6.6. Europe
    • 6.6.1. Market estimates and forecast, by country, 2016 - 2028 (USD Million)
    • 6.6.2. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
    • 6.6.3. Market volume and forecast, by product, 2016 - 2028 (Number of procedures)
    • 6.6.4. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
    • 6.6.5. Germany
      • 6.6.5.1. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
      • 6.6.5.2. Market volume and forecast, by product, 2016 - 2028 (Number of procedures)
      • 6.6.5.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
    • 6.6.6. U.K.
      • 6.6.6.1. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
      • 6.6.6.2. Market volume and forecast, by product, 2016 - 2028 (Number of procedures)
      • 6.6.6.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
    • 6.6.7. France
      • 6.6.7.1. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
      • 6.6.7.2. Market volume and forecast, by product, 2016 - 2028 (Number of procedures)
      • 6.6.7.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
    • 6.6.8. Italy
      • 6.6.8.1. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
      • 6.6.8.2. Market volume and forecast, by product, 2016 - 2028 (Number of procedures)
      • 6.6.8.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
    • 6.6.9. Spain
      • 6.6.9.1. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
      • 6.6.9.2. Market volume and forecast, by product, 2016 - 2028 (Number of procedures)
      • 6.6.9.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
    • 6.6.10. Switzerland
      • 6.6.10.1. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
      • 6.6.10.2. Market volume and forecast, by product, 2016 - 2028 (Number of procedures)
      • 6.6.10.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
    • 6.6.11. Netherland
      • 6.6.11.1. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
      • 6.6.11.2. Market volume and forecast, by product, 2016 - 2028 (Number of procedures)
      • 6.6.11.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
    • 6.6.12. Belgium
      • 6.6.12.1. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
      • 6.6.12.2. Market volume and forecast, by product, 2016 - 2028 (Number of procedures)
      • 6.6.12.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Market estimates and forecast, by country, 2016 - 2028 (USD Million)
    • 6.7.2. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
    • 6.7.3. Market volume and forecast, by product, 2016 - 2028 (Number of procedures)
    • 6.7.4. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
    • 6.7.5. China
      • 6.7.5.1. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
      • 6.7.5.2. Market volume and forecast, by product, 2016 - 2028 (Number of procedures)
      • 6.7.5.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
    • 6.7.6. Japan
      • 6.7.6.1. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
      • 6.7.6.2. Market volume and forecast, by product, 2016 - 2028 (Number of procedures)
      • 6.7.6.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
    • 6.7.7. India
      • 6.7.7.1. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
      • 6.7.7.2. Market volume and forecast, by product, 2016 - 2028 (Number of procedures)
      • 6.7.7.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
    • 6.7.8. Thailand
      • 6.7.8.1. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
      • 6.7.8.2. Market volume and forecast, by product, 2016 - 2028 (Number of procedures)
      • 6.7.8.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
    • 6.7.9. South Korea
      • 6.7.9.1. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
      • 6.7.9.2. Market volume and forecast, by product, 2016 - 2028 (Number of procedures)
      • 6.7.9.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
    • 6.7.10. Australia
      • 6.7.10.1. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
      • 6.7.10.2. Market volume and forecast, by product, 2016 - 2028 (Number of procedures)
      • 6.7.10.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
    • 6.7.11. Malaysia
      • 6.7.11.1. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
      • 6.7.11.2. Market volume and forecast, by product, 2016 - 2028 (Number of procedures)
      • 6.7.11.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
    • 6.7.12. Singapore
      • 6.7.12.1. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
      • 6.7.12.2. Market volume and forecast, by product, 2016 - 2028 (Number of procedures)
      • 6.7.12.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
    • 6.7.13. Indonesia
      • 6.7.13.1. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
      • 6.7.13.2. Market volume and forecast, by product, 2016 - 2028 (Number of procedures)
      • 6.7.13.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
    • 6.7.14. Philippines
      • 6.7.14.1. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
      • 6.7.14.2. Market volume and forecast, by product, 2016 - 2028 (Number of procedures)
      • 6.7.14.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Market estimates and forecast, by country, 2016 - 2028 (USD Million)
    • 6.8.2. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
    • 6.8.3. Market volume and forecast, by product, 2016 - 2028 (Number of procedures)
    • 6.8.4. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
    • 6.8.5. Brazil
      • 6.8.5.1. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
      • 6.8.5.2. Market volume and forecast, by product, 2016 - 2028 (Number of procedures)
      • 6.8.5.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
    • 6.8.6. Mexico
      • 6.8.6.1. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
      • 6.8.6.2. Market volume and forecast, by product, 2016 - 2028 (Number of procedures)
      • 6.8.6.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
    • 6.8.7. Argentina
      • 6.8.7.1. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
      • 6.8.7.2. Market volume and forecast, by product, 2016 - 2028 (Number of procedures)
      • 6.8.7.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
    • 6.8.8. Colombia
      • 6.8.8.1. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
      • 6.8.8.2. Market volume and forecast, by product, 2016 - 2028 (Number of procedures)
      • 6.8.8.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
    • 6.8.9. Chile
      • 6.8.9.1. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
      • 6.8.9.2. Market volume and forecast, by product, 2016 - 2028 (Number of procedures)
      • 6.8.9.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
  • 6.9. Middle East and Africa
    • 6.9.1. Market estimates and forecast, by country, 2016 - 2028 (USD Million)
    • 6.9.2. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
    • 6.9.3. Market volume and forecast, by product, 2016 - 2028 (Number of procedures)
      • 6.9.3.1. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
    • 6.9.4. South Africa
      • 6.9.4.1. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
      • 6.9.4.2. Market volume and forecast, by product, 2016 - 2028 (Number of procedures)
      • 6.9.4.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
    • 6.9.5. Saudi Arabia
      • 6.9.5.1. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
      • 6.9.5.2. Market volume and forecast, by product, 2016 - 2028 (Number of procedures)
      • 6.9.5.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
    • 6.9.6. UAE
      • 6.9.6.1. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
      • 6.9.6.2. Market volume and forecast, by product, 2016 - 2028 (Number of procedures)
      • 6.9.6.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
    • 6.9.7. Israel
      • 6.9.7.1. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
      • 6.9.7.2. Market volume and forecast, by product, 2016 - 2028 (Number of procedures)
      • 6.9.7.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
    • 6.9.8. Turkey
      • 6.9.8.1. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
      • 6.9.8.2. Market volume and forecast, by product, 2016 - 2028 (Number of procedures)
      • 6.9.8.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)

Chapter 7. Facial Injectable Market - Competitive Analysis

  • 7.1. Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
  • 7.2. Vendor Landscape
    • 7.2.1. List of key distributors and channel partners
  • 7.3. Key companies profiled
    • 7.3.1. ALLERGAN
      • 7.3.1.1. Company Overview
      • 7.3.1.2. Financial Performance
      • 7.3.1.3. Product Benchmarking
      • 7.3.1.4. Strategic Initiatives
    • 7.3.2. Ipsen
      • 7.3.2.1. Company Overview
      • 7.3.2.2. Financial Performance
      • 7.3.2.3. Product Benchmarking
      • 7.3.2.4. Strategic Initiatives
    • 7.3.3. Merz Pharma
      • 7.3.3.1. Company Overview
      • 7.3.3.2. Financial Performance
      • 7.3.3.3. Product Benchmarking
      • 7.3.3.4. Strategic Initiatives
    • 7.3.4. Suneva Medical, Inc.
      • 7.3.4.1. Company Overview
      • 7.3.4.2. Financial Performance
      • 7.3.4.3. Product Benchmarking
      • 7.3.4.4. Strategic Initiatives
    • 7.3.5. Medytox Inc.
      • 7.3.5.1. Company Overview
      • 7.3.5.2. Financial Performance
      • 7.3.5.3. Product Benchmarking
      • 7.3.5.4. Strategic Initiatives
    • 7.3.6. Sinclair Pharma
      • 7.3.6.1. Company Overview
      • 7.3.6.2. Financial Performance
      • 7.3.6.3. Product Benchmarking
      • 7.3.6.4. Strategic Initiatives
    • 7.3.7. Bloomage BioTechnology Corporation Limited
      • 7.3.7.1. Company Overview
      • 7.3.7.2. Financial Performance
      • 7.3.7.3. Product Benchmarking
      • 7.3.7.4. Strategic Initiatives
    • 7.3.8. Anika Therapeutics, Inc.
      • 7.3.8.1. Company Overview
      • 7.3.8.2. Financial Performance
      • 7.3.8.3. Product Benchmarking
      • 7.3.8.4. Strategic Initiatives
    • 7.3.9. Prollenium Medical Technologies Inc.
      • 7.3.9.1. Company Overview
      • 7.3.9.2. Financial Performance
      • 7.3.9.3. Product Benchmarking
      • 7.3.9.4. Strategic Initiatives
    • 7.3.10. Galderma S.A
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives.

List of Tables

  • Table 1 Global facial injectable market, by Region, 2016 - 2028 (USD Million)
  • Table 2 Global facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 3 Global facial injectable market, by product, 2016 - 2028 (Number of procedures)
  • Table 4 Global facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 5 North America facial injectable market, by country, 2016 - 2028 (USD Million)
  • Table 6 North America facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 7 North America facial injectable market, by product, 2016 - 2028 (Number of procedures)
  • Table 8 North America facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 9 U.S. facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 10 U.S. facial injectable market, by product, 2016 - 2028 (Number of procedures)
  • Table 11 U.S. facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 12 Canada facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 13 Canada facial injectable market, by product, 2016 - 2028 (Number of procedures)
  • Table 14 Canada facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 15 Europe facial injectable market, by country, 2016 - 2028 (USD Million)
  • Table 16 Europe facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 17 Europe facial injectable market, by product, 2016 - 2028 (Number of procedures)
  • Table 18 Europe facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 19 U.K. facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 20 U.K. facial injectable market, by product, 2016 - 2028 (Number of procedures)
  • Table 21 U.K. facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 22 Germany facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 23 Germany facial injectable market, by product, 2016 - 2028 (Number of procedures)
  • Table 24 Germany facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 25 France facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 26 France facial injectable market, by product, 2016 - 2028 (Number of procedures)
  • Table 27 France facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 28 Italy facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 29 Italy facial injectable market, by product, 2016 - 2028 (Number of procedures)
  • Table 30 Italy facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 31 Spain facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 32 Spain facial injectable market, by product, 2016 - 2028 (Number of procedures)
  • Table 33 Spain facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 34 Switzerland facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 35 Switzerland facial injectable market, by product, 2016 - 2028 (Number of procedures)
  • Table 36 Switzerland facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 37 Netherland facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 38 Netherland facial injectable market, by product, 2016 - 2028 (Number of procedures)
  • Table 39 Netherland facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 40 Belgium facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 41 Belgium facial injectable market, by product, 2016 - 2028 (Number of procedures)
  • Table 42 Belgium facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 43 Asia Pacific facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 44 Asia Pacific facial injectable market, by product, 2016 - 2028 (Number of procedures)
  • Table 45 Asia Pacific facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 46 Japan Facial Injectable Market, by product, 2016 - 2028 (USD Million)
  • Table 47 Japan facial injectable market, by product, 2016 - 2028 (Number of procedures)
  • Table 48 Japan Facial Injectable Market, by application, 2016 - 2028 (USD Million)
  • Table 49 China facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 50 China facial injectable market, by product, 2016 - 2028 (Number of procedures)
  • Table 51 China facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 52 India facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 53 India facial injectable market, by product, 2016 - 2028 (Number of procedures)
  • Table 54 India facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 55 Thailand facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 56 Thailand facial injectable market, by product, 2016 - 2028 (Number of procedures)
  • Table 57 Thailand facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 58 South Korea facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 59 South Korea facial injectable market, by product, 2016 - 2028 (Number of procedures)
  • Table 60 South Korea facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 61 Australia facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 62 Australia facial injectable market, by product, 2016 - 2028 (Number of procedures)
  • Table 63 Australia facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 64 Malaysia facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 65 Malaysia facial injectable market, by product, 2016 - 2028 (Number of procedures)
  • Table 66 Malaysia facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 67 Singapore facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 68 Singapore facial injectable market, by product, 2016 - 2028 (Number of procedures)
  • Table 69 Singapore facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 70 Indonesia facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 71 Indonesia facial injectable market, by product, 2016 - 2028 (Number of procedures)
  • Table 72 Indonesia facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 73 Philippines facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 74 Philippines facial injectable market, by product, 2016 - 2028 (Number of procedures)
  • Table 75 Philippines facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 76 Latin America facial injectable market, by country, 2016 - 2028 (USD Million)
  • Table 77 Latin America facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 78 Latin America facial injectable market, by product, 2016 - 2028 (Number of procedures)
  • Table 79 Latin America facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 80 Brazil facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 81 Brazil facial injectable market, by product, 2016 - 2028 (Number of procedures)
  • Table 82 Brazil facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 83 Mexico facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 84 Mexico facial injectable market, by product, 2016 - 2028 (Number of procedures)
  • Table 85 Mexico facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 86 Argentina facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 87 Argentina facial injectable market, by product, 2016 - 2028 (Number of procedures)
  • Table 88 Argentina facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 89 Colombia facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 90 Colombia facial injectable market, by product, 2016 - 2028 (Number of procedures)
  • Table 91 Colombia facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 92 Chile facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 93 Chile facial injectable market, by product, 2016 - 2028 (Number of procedures)
  • Table 94 Chile facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 95 Middle East & Africa facial injectable market, by country, 2016 - 2028 (USD Million)
  • Table 96 Middle East & Africa facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 97 Middle East & Africa facial injectable market, by product, 2016 - 2028 (Number of procedures)
  • Table 98 Middle East & Africa facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 99 South Africa facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 100 South Africa facial injectable market, by product, 2016 - 2028 (Number of procedures)
  • Table 101 South Africa facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 102 Saudi Arabia facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 103 Saudi Arabia facial injectable market, by product, 2016 - 2028 (Number of procedures)
  • Table 104 Saudi Arabia facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 105 UAE facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 106 UAE facial injectable market, by product, 2016 - 2028 (Number of procedures)
  • Table 107 UAE facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 108 Israel facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 109 Israel facial injectable market, by product, 2016 - 2028 (Number of procedures)
  • Table 110 Israel facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 111 Turkey Facial Injectable Market, by product, 2016 - 2028 (USD Million)
  • Table 112 Turkey facial injectable market, by product, 2016 - 2028 (Number of procedures)
  • Table 113 Turkey Facial Injectable Market, by application, 2016 - 2028 (USD Million)

List of Figures

  • Figure 1 Market research process
  • Figure 2 Information procurement
  • Figure 3 Primary research pattern
  • Figure 4 Market research approaches
  • Figure 5 Value chain-based sizing & forecasting
  • Figure 6 QFD modelling for market share assessment
  • Figure 7 Market formulation & validation
  • Figure 8 Facial injectable market segmentation
  • Figure 9 Market driver relevance analysis (Current & future impact)
  • Figure 10 Market restraint relevance analysis (Current & future impact)
  • Figure 11 Market challenge relevance analysis (Current & future impact)
  • Figure 12 Penetration & growth prospect mapping
  • Figure 13 SWOT analysis, by factor (political & legal, economic and technological)
  • Figure 14 Porter's five forces analysis
  • Figure 15 Market penetration vs growth prospect mapping
  • Figure 16 Facial injectable market: product movement analysis
  • Figure 17 Regional marketplace: Key takeaways
  • Figure 18 Regional outlook, 2020 & 2028
  • Figure 19 North America facial injectable market, 2016 - 2028 (USD Million)
  • Figure 20 North America facial injectable market, 2016 - 2028 (Number of procedures)
  • Figure 21 U.S. facial injectable market, 2016 - 2028 (USD Million)
  • Figure 22 U.S. facial injectable market, 2016 - 2028 (Number of procedures)
  • Figure 23 Canada facial injectable market, 2016 - 2028 (USD Million))
  • Figure 24 Canada facial injectable market, 2016 - 2028 (Number of procedures)
  • Figure 25 Europe facial injectable market, 2016 - 2028 (USD Million)
  • Figure 26 Europe facial injectable market, 2016 - 2028 (Number of procedures)
  • Figure 27 U.K. facial injectable market, 2016 - 2028 (USD Million)
  • Figure 28 U.K. facial injectable market, 2016 - 2028 (Number of procedures)
  • Figure 29 Germany facial injectable market, 2016 - 2028 (USD Million)
  • Figure 30 Germany facial injectable market, 2016 - 2028 (Number of procedures)
  • Figure 31 Italy facial injectable market, 2016 - 2028 (USD Million)
  • Figure 32 Italy facial injectable market, 2016 - 2028 (Number of procedures)
  • Figure 33 Spain facial injectable market, 2016 - 2028 (USD Million)
  • Figure 34 Spain facial injectable market, 2016 - 2028 (Number of procedures)
  • Figure 35 France facial injectable market, 2016 - 2028 (USD Million)
  • Figure 36 France facial injectable market, 2016 - 2028 (Number of procedures)
  • Figure 37 Switzerland facial injectable market, 2016 - 2028 (USD Million)
  • Figure 38 Switzerland facial injectable market, 2016 - 2028 (Number of procedures)
  • Figure 39 Netherland facial injectable market, 2016 - 2028 (USD Million)
  • Figure 40 Netherland facial injectable market, 2016 - 2028 (Number of procedures)
  • Figure 41 Belgium facial injectable market, 2016 - 2028 (USD Million)
  • Figure 42 Belgium facial injectable market, 2016 - 2028 (Number of procedures)
  • Figure 43 Asia Pacific facial injectable market, 2016 - 2028 (USD Million)
  • Figure 44 Asia Pacific facial injectable market, 2016 - 2028 (Number of procedures)
  • Figure 45 Japan facial injectable market, 2016 - 2028 (USD Million)
  • Figure 46 Japan facial injectable market, 2016 - 2028 (Number of procedures)
  • Figure 47 China facial injectable market, 2016 - 2028 (USD Million)
  • Figure 48 China facial injectable market, 2016 - 2028 (Number of procedures)
  • Figure 49 India facial injectable market, 2016 - 2028 (USD Million)
  • Figure 50 India facial injectable market, 2016 - 2028 (Number of procedures)
  • Figure 51 Thailand facial injectable market, 2016 - 2028 (USD Million)
  • Figure 52 Thailand facial injectable market, 2016 - 2028 (Number of procedures)
  • Figure 53 South Korea facial injectable market, 2016 - 2028 (USD Million)
  • Figure 54 South Korea facial injectable market, 2016 - 2028 (Number of procedures)
  • Figure 55 Australia facial injectable market, 2016 - 2028 (USD Million)
  • Figure 56 Australia facial injectable market, 2016 - 2028 (Number of procedures)
  • Figure 57 Malaysia facial injectable market, 2016 - 2028 (USD Million)
  • Figure 58 Malaysia facial injectable market, 2016 - 2028 (Number of procedures)
  • Figure 59 Singapore facial injectable market, 2016 - 2028 (USD Million)
  • Figure 60 Singapore facial injectable market, 2016 - 2028 (Number of procedures)
  • Figure 61 Indonesia facial injectable market, 2016 - 2028 (USD Million)
  • Figure 62 Indonesia facial injectable market, 2016 - 2028 (Number of procedures)
  • Figure 63 Philippines facial injectable market, 2016 - 2028 (USD Million)
  • Figure 64 Philippines facial injectable market, 2016 - 2028 (Number of procedures)
  • Figure 65 Latin America facial injectable market, 2016 - 2028 (USD Million)
  • Figure 66 Latin America facial injectable market, 2016 - 2028 (Number of procedures)
  • Figure 67 Brazil facial injectable market, 2016 - 2028 (USD Million)
  • Figure 68 Brazil facial injectable market, 2016 - 2028 (Number of procedures)
  • Figure 69 Mexico facial injectable market, 2016 - 2028 (USD Million)
  • Figure 70 Mexico facial injectable market, 2016 - 2028 (Number of procedures)
  • Figure 71 Argentina facial injectable market, 2016 - 2028 (USD Million)
  • Figure 72 Argentina facial injectable market, 2016 - 2028 (Number of procedures)
  • Figure 73 Colombia facial al injectable market, 2016 - 2028 (USD Million)
  • Figure 74 Colombia facial injectable market, 2016 - 2028 (Number of procedures)
  • Figure 75 Chile facial al injectable market, 2016 - 2028 (USD Million)
  • Figure 76 Chile facial injectable market, 2016 - 2028 (Number of procedures)
  • Figure 77 MEA facial injectable market, 2016 - 2028 (USD Million)
  • Figure 78 MEA facial injectable market, 2016 - 2028 (Number of procedures)
  • Figure 79 South Africa facial injectable market, 2016 - 2028 (USD Million)
  • Figure 80 South Africa facial injectable market, 2016 - 2028 (Number of procedures)
  • Figure 81 Saudi Arabia facial injectable market, 2016 - 2028 (USD Million)
  • Figure 82 Saudi Arabia facial injectable market, 2016 - 2028 (Number of procedures)
  • Figure 83 UAE facial injectable market, 2016 - 2028 (USD Million)
  • Figure 84 UAE facial injectable market, 2016 - 2028 (Number of procedures)
  • Figure 85 Israel facial injectable market, 2016 - 2028 (USD Million)
  • Figure 86 Israel facial injectable market, 2016 - 2028 (Number of procedures)
  • Figure 87 Turkey facial injectable market, 2016 - 2028 (USD Million)
  • Figure 88 Turkey facial injectable market, 2016 - 2028 (Number of procedures)